PACS Group Analyst Price Targets - Benzinga

PACS Group Inc

PACSNYSE

Trade with Public

Trade with Public

$42.85

1.824.44%

Últ. Act.: Oct 2, 4:26 PM

$43.00

1.974.8%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

PACS Group Analyst Price Targets - Benzinga

PACS Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for PACS Group (PACS).

Price Target Range — 8 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$44Upside to Avg. PT+2.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 4, 2026	JP Morgan	Benjamin Rossi	PT Raise	Overweight	$47→$58
Aug 10, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$48→$57
Aug 6, 2026	UBS	A.J. Rice	PT Raise	Buy	$57→$60
Aug 6, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$52→$57
Aug 6, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$52→$62
Jul 8, 2026	UBS	A.J. Rice	PT Raise	Buy	$50→$57
May 18, 2026	Truist Securities	David Macdonald	PT Raise	Buy	$50→$52
May 13, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$42→$48
Mar 4, 2026	UBS	A.J. Rice	PT Raise	Buy	$42→$44
Mar 4, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$40→$42
Feb 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$47→$52
Dec 18, 2025	UBS	A.J. Rice	PT Cut	Buy	$50→$42
Dec 17, 2025	JP Morgan	Benjamin Rossi	Reinstates	Overweight	$44
Nov 20, 2025	RBC Capital	Ben Hendrix	PT Raise	Outperform	$32→$33
Jan 6, 2025	Macquarie	Tao Qiu	PT Cut	Outperform	$42→$24
Jan 6, 2025	Truist Securities	David Macdonald	PT Cut	Buy	$46→$32
Dec 17, 2024	JP Morgan	Lisa Gill	Downgrade	Overweight→Neutral	$18
Nov 18, 2024	Stephens & Co.	Scott Fidel	PT Cut	Overweight	$48→$31
Nov 6, 2024	JP Morgan	Lisa Gill	Reinstates	Overweight	$40
Oct 14, 2024	Truist Securities	David Macdonald	PT Raise	Buy	$44→$46

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58

JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $57

Oppenheimer analyst Michael Wiederhorn maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $48 to $57.

Benzinga Newsdesk

PRO
UBS Maintains Buy on PACS Group, Raises Price Target to $60

UBS analyst A.J. Rice maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $57 to $60.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on PACS Group, Raises Price Target to $57

RBC Capital analyst Ben Hendrix maintains PACS Group (NYSE:PACS) with a Outperform and raises the price target from $52 to $57.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on PACS Group, Raises Price Target to $62

Truist Securities analyst David Macdonald maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $52 to $62.

Benzinga Newsdesk

PRO
UBS Maintains Buy on PACS Group, Raises Price Target to $57

UBS analyst A.J. Rice maintains PACS Group (NYSE:PACS) with a Buy and raises the price target from $50 to $57.

Benzinga Newsdesk